Laurion Capital Management »

Prime Medicine shares owned by Laurion Capital Management

Quarter-by-quarter ownership of Prime Medicine (PRME) shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in Prime Medicine

Tip: Access up to 7 years of quarterly data

All positions including Prime Medicine held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prime Medicine by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $819k 56k 14.65
2023-03-31 $738k 60k 12.30
2022-12-31 $1.1M 60k 18.58

More positions owned by Laurion Capital Management

Ishares Tr Iboxx Hi Yd Etf (HYG)
Meta Platforms Cl A Call Option (META)
Apple (AAPL)
Tesla Motors Call Option (TSLA)
Kenvue (KVUE)
Microsoft Corporation Call Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Adobe Systems Incorporated Call Option (ADBE)
Alphabet Cap Stk Cl C Call Option (GOOG)
Bridgebio Pharma (BBIO)
NVIDIA Corporation Call Option (NVDA)
Bank of America Corporation (BAC)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Intel Corporation Call Option (INTC)

View all positions for Laurion Capital Management

Top funds holding Prime Medicine

Alphabet
ARK Investment Management
Vanguard Group
Nikko Asset Management Americas
Sumitomo Mitsui Trust Holdings
T. Rowe Price Associates
Redmile Group
Baker Bros. Advisors
Deerfield Management Company
Greenwich Wealth Management
Bank of America Corporation
Samsara BioCapital
Casdin Capital
Charles Schwab Investment Management
Two Sigma Investments

View all funds holding Prime Medicine